Argentina Dermatological Drugs Market Size & Outlook
Argentina dermatological drugs market, 2018-2030 (US$M)
Related Markets
Argentina dermatological drugs market highlights
- The Argentina dermatological drugs market generated a revenue of USD 113.6 million in 2024 and is expected to reach USD 202.8 million by 2030.
- The Argentina market is expected to grow at a CAGR of 10.2% from 2025 to 2030.
- In terms of segment, psoriasis was the largest revenue generating therapy in 2024.
- Psoriasis is the most lucrative therapy segment registering the fastest growth during the forecast period.
Dermatological drugs market data book summary
| Market revenue in 2024 | USD 113.6 million |
| Market revenue in 2030 | USD 202.8 million |
| Growth rate | 10.2% (CAGR from 2025 to 2030) |
| Largest segment | Psoriasis |
| Fastest growing segment | Psoriasis |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.5% of the global dermatological drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil dermatological drugs market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 202.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatological Drugs Market Scope
Dermatological Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina dermatological drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.7% in 2024. Horizon Databook has segmented the Argentina dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina's dermatological drugs market is witnessing gradual growth, driven by the increasing prevalence of skin conditions such as acne and psoriasis, alongside growing awareness of dermatological health. The country’s healthcare system and rising disposable income are contributing to the demand for dermatological treatments. Furthermore, the increasing popularity of aesthetic dermatology and anti-aging treatments is supporting market growth. The rising awareness and accessibility of dermatological care, coupled with an expanding focus on aesthetics, are key factors influencing this demand.
As the market develops, the introduction of new treatments, including biologics, is expected to further drive growth. The expanding use of telemedicine and better access to healthcare are also anticipated to contribute positively to market expansion during the forecast period. These factors suggest continued demand for innovative solutions to address the country's dermatological needs.
Reasons to subscribe to Argentina dermatological drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina dermatological drugs market databook
-
Our clientele includes a mix of dermatological drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina dermatological drugs market , including forecasts for subscribers. This country databook contains high-level insights into Argentina dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina dermatological drugs market size, by indication, 2018-2030 (US$M)
Argentina Dermatological Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
